Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. MSFT
6. NVDA
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30

Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'

August 11, 2014 11:05 AM EDT

Aegis Capital affirms Inovio Pharmaceuticals (AMEX: INO) at Buy with a target price of $19 following Q2 results and update released earlier Monday.

Analyst Ram Selvaraju commented, This morning, Inovio reported financial results for the second quarter of 2014. The firm closed the... More

Inovio Pharmaceuticals (INO) Posts Narrower than Expected Q2 Loss of 18c/Share

August 11, 2014 9:17 AM EDT

Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q2 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $1.8 million.

Dr. J. Joseph Kim, President and CEO, said, "Our second quarter marked a historical... More